Immune Dysfunction and Bacterial Coinfections following Influenza
- 1 September 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 191 (5) , 2047-2052
Abstract
Secondary pulmonary infections by encapsulated bacteria including Streptococcus pneumoniae and Staphylococcus aureus following influenza represent a common and challenging clinical problem. The reasons for this polymicrobial synergy are still not completely understood, hampering development of effective prophylactic and therapeutic interventions. Although it has been commonly thought that viral-induced epithelial cell damage allows bacterial invasiveness, recent studies by several groups have now implicated dysfunctional innate immune defenses following influenza as the primary culprit for enhanced susceptibility to secondary bacterial infections. Understanding the immunological imbalances that are responsible for virus/bacteria synergy will ultimately allow the design of effective, broad-spectrum therapeutic approaches for prevention of enhanced susceptibility to these pathogens.Keywords
This publication has 77 references indexed in Scilit:
- IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) VirusCell Research, 2011
- A Postinfluenza Model ofStaphylococcus aureusPneumoniaThe Journal of Infectious Diseases, 2010
- Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10Nature Medicine, 2009
- Treatment with Protein Synthesis Inhibitors Improves Outcomes of Secondary Bacterial Pneumonia after InfluenzaThe Journal of Infectious Diseases, 2009
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008
- The Bacteria Fight Back2008
- Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infectionJournal of Experimental Medicine, 2008
- The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenzaScandinavian Journal of Infectious Diseases, 2008
- Expression of the 1918 Influenza A Virus PB1-F2 Enhances the Pathogenesis of Viral and Secondary Bacterial PneumoniaCell Host & Microbe, 2007
- Insights into the Interaction between Influenza Virus and PneumococcusClinical Microbiology Reviews, 2006